Sun Pharma, the public-private partnership (PPP) for the first time collaborated with Indian Council of Medical Research (ICMR) to destroy the disease, Malaria by 2030. With this programme, ICMR and Sun Pharma raised ‘Malaria Free India’ to support the National Framework for eradicating Malaria that which is announced by Health Ministry in February 2016.

“The project will first be launched in a malaria-ridden district of Mandla in Madhya Pradesh,” said Altaf Lal, senior advisor Global Health & Innovation at Sun Pharma. The company did some survey before choosing Mandla he said. He also said that the company would look to another place when there is an issue of Malaria.

“The idea of this partnership is to use our understanding and knowledge for the success of this project. We will be working with global agencies to make the project a success,” said Dilip Shanghvi, managing director of Sun Pharma.

“The first of its kind PPP agreement reiterates India’s commitment to eliminate malaria. ICMR and Sun Pharma will aim to reduce the morbidity and mortality caused by malaria in this demonstration project as well as prevention of re-introduction of malaria,” said J.P. Nadda, Union minister of health and family welfare.

Sun Pharma is later adding more diseases like tuberculosis and diabetes in this list of eradication over a period of time.